Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 758Sesión 2025-2026

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.

Printer's No. PN0782

See other bills
under the
same topic PRINTER'S NO. 782 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.758 Session of 2025 INTRODUCED BY BURGOS, KENYATTA, MALAGARI, GIRAL, HOHENSTEIN, CEPEDA-FREYTIZ, SANCHEZ, HILL-EVANS, DONAHUE, CIRESI, CERRATO AND GREEN, MARCH 3, 2025 REFERRED TO COMMITTEE ON JUDICIARY, MARCH 3, 2025 AN ACTAmending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for prohibited acts and penalties.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 13(g) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, is amended to read:Section 13. Prohibited Acts; Penalties.--* * *(g) Any person who violates clause (31) of subsection (a) is guilty of a [misdemeanor] summary offense and upon conviction thereof shall be [sentenced to imprisonment not exceeding thirty days, or] ordered to pay a fine not exceeding [five hundred dollars ($500), or both] twenty-five dollars ($25).12345678910111213141516171819202122 * * *Section 2. This act shall take effect in 60 days.20250HB0758PN0782 - 2 - 12

Texto oficial de la Legislatura de Pennsylvania. El formato se adaptó para leerlo en Ratifi.